Effects of corticosteroids on HCV infection.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  International Journal of Immunopharmacology

• Publication date

  1999-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0192-0561(99)00005-3PMID 10408633
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long‐term outcome of hepatitis C virus infection after liver transplantation

  1997cited by this paper
• Long-term outcome of hepatitis C infection after liver transplantation.

  1996cited by this paper
• A longitudinal analysis of hepatitis C virus replication following liver transplantation.

  1996cited by this paper
• Recurrent hepatitis C virus hepatitis in liver transplant recipients receiving tacrolimus: association with rejection and increased immunosuppression after transplantation.

  1996cited by this paper
• In vitro infection of peripheral blood mononuclear cells by hepatitis C virus.

  1995cited by this paper
• Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation

  1995cited by this paper
• [Clinical and virological aspects of hepatitis C virus infection in liver transplantation].

  1995cited by this paper
• Persistent hepatitis C virus infection after liver transplantation: Clinical and virological features

  1995cited by this paper
• Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C.

  1994cited by this paper
• Hepatitis C viremia in chronic liver disease: Relationship to interferon‐α or corticosteroid treatment

  1994cited by this paper
• Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment.

  1994cited by this paper
• Quantitation of hepatitis C virus RNA in liver transplant recipients

  1994cited by this paper
• Quantitation of hepatitis C virus RNA in liver transplant recipients.

  1994cited by this paper
• Nitroblue tetrazolium reduction in monocytes and monocyte‐derived macrophages

  1989cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper

• Reactivation of hepatitis C virus caused by steroid monotherapy for sudden deafness

  2024cites this paper
• Efficacy and safety of rituximab in patients with PLA2R associated membranous nephropathy and resolved HCV infection

  2024cites this paper
• A case of acute exacerbation of chronic hepatitis C during the course of adrenal Cushing's syndrome

  2021cites this paper
• Reactivation of hepatitis C virus with severe hepatitis flare during steroid administration for interstitial pneumonia

  2021cites this paper
• Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies

  2020cites this paper
• Clinical Profile of Patients With Diabetes Mellitus and Liver Transplantation: Results After a Multidisciplinary Team Intervention.

  2018cites this paper
• Chemotherapy and targeted therapy for breast cancer patients with hepatitis C virus infection

  2018cites this paper
• Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study

  2018influential citation
• Advances in HCV and Cryoglobulinemic Vasculitis in the Era of DAAs: Are We at the End of the Road?

  2017cites this paper
• Prevalence and risk factors of new onset diabetes after liver transplantation (NODAT): A single Egyptian center experience

  2017cites this paper
• A Young Man Dying Of Fulminant Hepato-Renal Syndrome. The Tagging To Alcohol Addiction Obscured the Diagnosis and Precluded the Treatment of Chronic Viral Hepatitis (HBV, HCV, HDV) As the Cause of His Liver Cirrhosis

  2017cites this paper
• Treatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug Therapy

  2016cites this paper
• Immunology of Liver Transplantation

  2016cites this paper
• A retrospective 15‐year review: survival advantage after switching to sirolimus in hepatitis C virus infected liver graft recipients

  2015cites this paper
• Incidence and antiviral response of hepatitis C virus reactivation in lupus patients undergoing immunosuppressive therapy

  2015cites this paper
• Approach and management of patients with chronic hepatitis B and C during the course of inflammatory bowel disease.

  2014cites this paper
• An update on the management of hepatitis C virus-related arthritis

  2014cites this paper
• Association between CYP 3 A 5 Genotypes in Graft Liver and Increase in Tacrolimus Biotransformation from Steroid Treatment in Living-donor Liver Transplant Patients

  2014cites this paper
• Association between CYP3A5 genotypes in graft liver and increase in tacrolimus biotransformation from steroid treatment in living-donor liver transplant patients.

  2014cites this paper
• Hepatitis C virus (HCV) reactivation caused by steroid therapy for dermatomyositis.

  2014cites this paper
• Does low‐dose prolonged steroid therapy affect the natural history of chronic hepatitis C?

  2014cites this paper
• How important is acute cellular rejection?

  2013cites this paper
• Efficacy and safety of treatment of hepatitis C in patients with inflammatory bowel disease.

  2013cites this paper
• Rheumatologic Symptoms in Patients with Mixed Cryoglobulinemia

  2012cites this paper
• A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis.

  2012cites this paper
• Natural History of Chronic HCV After Liver Transplantation

  2012cites this paper
• New-onset diabetes mellitus: predictive factors and impact on the outcome of patients undergoing liver transplantation.

  2012cites this paper
• Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer

  2012cites this paper
• Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease

  2011cites this paper
• Management of Reactivation of Hepatitis B and Hepatitis C During Antineoplastic Therapy

  2011cites this paper
• Hepatitis C Virus Therapy-related Skin Manifestations.

  2010cites this paper
• A new approach for treatment of hepatitis C in hepatitis C-autoimmune hepatitis overlap syndrome.

  2010cites this paper
• adaptation Criteria Grid Best Practices and Interventions for the Prevention and Awareness of Hepatitis C

  2010cites this paper
• HCV genotype 2 as a risk factor for reactivation in patients with B‐cell lymphoma undergoing rituximab combination chemotherapy

  2010cites this paper
• A new approach for treatment of hepatitis C in hepatitis C-autoimmune hepatitis overlap syndrome.

  2010cites this paper
• Diagnosis and management of interstitial pneumonitis associated with interferon therapy for chronic hepatitis C.

  2010cites this paper
• How HCV has changed the approach to mixed cryoglobulinemia.

  2009cites this paper
• A prospective randomized open study in liver transplant recipients: Daclizumab, mycophenolate mofetil, and tacrolimus versus tacrolimus and steroids

  2009cites this paper
• Inflammatory bowel disease and hepatitis€B and C

  2009cites this paper
• Inflammatory bowel disease and hepatitis B and C.

  2009cites this paper
• Maladies inflammatoires chroniques intestinales et hépatites B et C

  2009cites this paper
• Adverse skin reactions associated with hepatitis C treatment: Comment

  2008cites this paper
• Liver dysfunction after chemotherapy in lymphoma patients infected with hepatitis C

  2008cites this paper
• Corticothérapie systémique et risque infectieux

  2007cites this paper
• Neuroendocrine regulation of cancer progression: I. Biological mechanisms and clinical relevance

  2007cites this paper
• Corticosteroid-Induced Adverse Events in Adults

  2007cites this paper
• Corticosteroid‐free immunosuppression with daclizumab in HCV+ liver transplant recipients: 1‐year interim results of the HCV‐3 study

  2007cites this paper
• Initial steroid bolus injection promotes vigorous CD8+ alloreactive responses toward early graft acceptance immediately after liver transplantation in humans

  2007cites this paper
• Alcoholic steatohepatitis: Management and prognosis

  2007cites this paper
• [Systemic corticosteroid treatment and risk of infectious diseases].

  2007cites this paper
• Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop.

  2006cites this paper
• Syncytial giant cell hepatitis in human immunodeficiency virus-infected patients with chronic hepatitis C: 2 cases and review of the literature.

  2006cites this paper
• Liver transplantation for hepatitis C.

  2006cites this paper
• Intestinal MDR1/ABCB1 level at surgery as a risk factor of acute cellular rejection in living‐donor liver transplant patients

  2006cites this paper
• Scarce influence of corticosteroid boluses on long-term viral load and liver histology in transplanted patients with recurrent hepatitis C.

  2006cites this paper
• The influence of bio-behavioural factors on tumour biology: pathways and mechanisms

  2006cites this paper
• Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature.

  2005cites this paper
• Management of hepatitis C virus-related arthritis

  2005cites this paper
• Superpotent Topical Steroid Therapy for Epidermolysis bullosa acquisita

  2004cites this paper
• Steroid avoidance in liver transplantation.

  2004cites this paper
• Interferon-alpha-associated sarcoidosis responsive to infliximab therapy.

  2004cites this paper
• The long-term effects of immune suppression on liver transplant recipients with recurrent hepatitis C viral infection.

  2004cites this paper
• Adjuvant drugs for end-stage liver failure and transplantation.

  2004cites this paper
• Initial steroid-free immunosuppression after liver transplantation in recipients with hepatitis C virus related cirrhosis.

  2004cites this paper
• Living donor liver transplantation and hepatitis C

  2004cites this paper
• Hepatitis C virus infection in systemic lupus erythematosus: a case-control study.

  2003cites this paper
• Allograft transmission of hepatitis C virus infection from infected donors in cardiac transplantation

  2003cites this paper
• Mycophenolate mofetil in the treatment of autoimmune HCV‐associated haematological disorders showing steroid resistance or dependence

  2003cites this paper
• Living donor liver transplantation and hepatitis C.

  2003cites this paper
• Hepatitis C and the skin.

  2002cites this paper
• Adjunct drugs in liver transplantation

  2002cites this paper
• POSTTRANSPLANT DIABETES MELLITUS IN LIVER TRANSPLANT RECIPIENTS: RISK FACTORS, TEMPORAL RELATIONSHIP WITH HEPATITIS C VIRUS ALLOGRAFT HEPATITIS, AND IMPACT ON MORTALITY1

  2001cites this paper
• Glucocorticosteroids for viral hepatitis C.

  2001cites this paper
• Traitement chimiothérapique ou immunosuppresseur chez les malades infectés par les virus de l'hépatite B ou C

  2001cites this paper
• Coevolutionary networks: a novel approach to understanding the relationships of humans with the infectious agents.

  2001cites this paper
• Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome.

  2001cites this paper
• [Chemotherapy and immunosuppression in patients with hepatitis B or C].

  2001cites this paper
• Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies

  2001cites this paper
• Results of steroid-based therapy for the hepatitis C–autoimmune hepatitis overlap syndrome

  2001cites this paper
• Immunosuppression in Liver Transplantation

  2000cites this paper